文献速递角膜与眼表疾病神经眼科

衰老对小鼠和人类角膜神经形态及P物质表达的影响

The Effect of Aging on Nerve Morphology and Substance P Expression in Mouse and Human Corneas.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究通过ELISA、免疫荧光和活体共聚焦显微镜,检测小鼠和人类角膜中P物质(SP)水平与总神经长度(TNL)随年龄的变化。结果显示,小鼠和人类角膜SP与神经共定位,衰老伴随SP水平和TNL下降,SP敲除小鼠神经丢失更显著且痛觉受损,局部SP治疗可恢复敏感性。

要点

  • 衰老伴随小鼠和人类角膜SP水平及总神经长度下降。
  • SP敲除小鼠神经长度减少更显著,痛觉受损,局部SP可恢复敏感性。
  • SP参与维持角膜神经形态并调节痛觉。

核心结论

  • 衰老相关的角膜神经丢失与小鼠和人类角膜SP表达下降相平行。
  • SP长期促进角膜正常神经形态的维持并调节角膜痛觉。

研究设计与样本

  • 使用野生型和SP敲除小鼠角膜及人类角膜和泪液,通过ELISA定量SP水平。
  • 小鼠全mount β3-tubulin免疫荧光和人类活体激光角膜共聚焦显微镜测量角膜总神经长度(TNL)。
  • 小鼠通过擦拭试验评估眼表痛觉。

主要发现

  • SP与小鼠和人类角膜上皮下神经共定位。
  • 野生型小鼠SP水平随年龄下降(P=0.0045,8 vs. 52周;P=0.004,26 vs. 52周),TNL也下降(P=0.018,8 vs. 26周;P=0.0001,8 vs. 52周)。
  • SP敲除小鼠TNL下降幅度大于野生型(8 vs. 26周,P=0.0016)。
  • 最老野生型和年龄匹配的敲除小鼠痛觉受损(P=0.007和P<0.0001),局部SP治疗恢复敲除小鼠敏感性。
  • 人类老年人角膜SP水平降低,泪液SP与年龄相关(P=0.0368),TNL在老年患者中下降(P=0.0002)。

关键数值与推荐

  • 小鼠SP水平年龄比较:8 vs. 52周 P=0.0045;26 vs. 52周 P=0.004。
  • 小鼠TNL年龄比较:8 vs. 26周 P=0.018;8 vs. 52周 P=0.0001。
  • SP敲除小鼠TNL比较:8 vs. 26周 P=0.0016。
  • 最老野生型和敲除小鼠痛觉比较:P=0.007和P<0.0001。
  • 人类泪液SP与年龄相关:P=0.0368;人类TNL老年比较:P=0.0002。

临床怎么用

  • 角膜神经密度和SP表达随年龄下降,提示衰老角膜神经退变风险。
  • SP水平或可作为评估角膜神经状态和痛觉功能的潜在指标。
  • 局部SP治疗在动物模型中恢复痛觉敏感性,提示潜在干预方向。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Aging impairs corneal nerve density and sensitivity. Substance P (SP), a neuropeptide secreted by sensory nerves, regulates nerve morphology and nociception. Here, we investigate the relationship between aging, nerve morphology, and SP expression in mouse and human corneas. METHODS: SP levels in mouse corneas (wild type and substance P-knockout) and human corneas and tears were quantified with an ELISA assay. Corneal total nerve length (TNL) was measured with whole-mount β3-tubulin immunofluorescence in mouse and in vivo laser corneal confocal microscopy in humans. SP and β3-tubulin stained cross-sections were used to assess the colocalization of SP and nerves in human and mouse corneas. Ocular surface nociception was assessed with a wiping test in mice. RESULTS: SP colocalizes with sub-basal neurons in mice and humans. In WT mice, SP levels decrease with age (P = 0.0045, 8 vs. 52 weeks; P = 0.004, 26 vs. 52 weeks) as well as TNL (P = 0.018, 8 vs. 26 weeks; P = 0.0001, 8 vs. 52 weeks). Knockout mice show a greater TNL reduction (8 vs. 26 weeks, P = 0.0016) than WT mice. In the oldest WT and age-matched KO mice, nociception is impaired (P = 0.007 and P < 0.0001, respectively), and KO mice sensitivity is restored by topical SP treatment. In humans, SP levels are reduced in old subject corneas and correlate, in tears, with age (P = 0.0368); TNL also decreases in older patients (P = 0.0002). CONCLUSIONS: Age-associated corneal nerve loss is paralleled by reduction of SP expression in mice and humans. SP promotes the maintenance of normal nerve morphology in the long term and modulates nociception in the cornea.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Marco B, Alessandro R, Philippe F, et al. The Effect of Aging on Nerve Morphology and Substance P Expression in Mouse and Human Corneas. Invest Ophthalmol Vis Sci. 2018. PMID: 30398624. doi:10.1167/iovs.18-24707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。